Illustration: COVID-19 Drugs

SUQIAN, CHINA - JANUARY 30, 2023 - Illustration: COVID-19 drugs, Suqian, Jiangsu Province, China, Jan 30, 2023. The State Food and Drug Administration conditionally approved the marketing of the novel coronavirus infection treatment drug Synnotvir tablet/Ritonavir tablet in combination package and Remidavir deuterium hydrobromide tablet. (Photo credit should read CFOTO/Future Publishing via Getty Images)
SUQIAN, CHINA - JANUARY 30, 2023 - Illustration: COVID-19 drugs, Suqian, Jiangsu Province, China, Jan 30, 2023. The State Food and Drug Administration conditionally approved the marketing of the novel coronavirus infection treatment drug Synnotvir tablet/Ritonavir tablet in combination package and Remidavir deuterium hydrobromide tablet. (Photo credit should read CFOTO/Future Publishing via Getty Images)
Illustration: COVID-19 Drugs
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesIllustration: COVID-19 Drugs, News PhotoIllustration: COVID-19 Drugs, News PhotoIllustration: COVID-19 Drugs Get premium, high resolution news photos at Getty ImagesProduct #:1246656521
$499$175
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.China Out
Credit:
CFOTO / Contributor
Editorial #:
1246656521
Collection:
Future Publishing
Date created:
January 30, 2023
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Future Publishing
Object name:
Illustration: COVID-19 Drugs
Max file size:
4608 x 3456 px (15.36 x 11.52 in) - 300 dpi - 2 MB